These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 33526319
1. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis. Hamada S, Kobayashi Y, Sakamoto D, Shimamura A, Kuroda K, Kawachi R, Kanda A, Asako M, Gotoh M, Okubo K, Tomoda K, Iwai H. Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319 [Abstract] [Full Text] [Related]
2. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis. Fujii T, Kitamura Y, Kamimura S, Naito K, Takeda N. Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852 [Abstract] [Full Text] [Related]
4. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, Murata T, Nakao Y, Kanazawa C, Nagakura H, Okawa T, Nakano K, Hisamitsu M, Kaneko S, Konno A. Int Arch Allergy Immunol; 2015 Aug; 166(3):177-88. PubMed ID: 25895909 [Abstract] [Full Text] [Related]
6. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis. Kikuoka H, Kouzaki H, Matsumoto K, Arai H, Yamamoto S, Tojima I, Shimizu S, Miyashita H, Ogawa Y, Osada T, Okano M, Yuta A, Shimizu T. Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749 [Abstract] [Full Text] [Related]
7. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy. Otsuka K, Otsuka H, Matsune S, Okubo K. Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704 [Abstract] [Full Text] [Related]
9. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial. Nomura Y, Okubo K, Nakamura T, Sawaki S, Kitagou H, Idei N, Kaneko S, Kobayashi S, Tanaka Y, Okamoto Y. Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209 [Abstract] [Full Text] [Related]
11. [A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD]. Oka A, Yuta A, Okawa Y, Masuno S, Tsunoda T, Takahara E, Terada A, Kanai K, Nagakura H, Mimura H, Arao H, Ueyama S, Ueyama A, Tokuda R, Bamba H, Nakazato H, Nakazato M, Amesara R, Nakai S, Araki S, Sakaida M, Tokuriki M, Hama T, Chiba M, Ikeda H, Togawa A, Tsuzuki H, Hyo Y, Niitsu S, Ohkawa C, Nakamoto S, Takeo T, Kumanomidou H, Kanai K, Kitamura H, Sugiura R, Okano M. Arerugi; 2023 Jan; 72(9):1138-1146. PubMed ID: 37967960 [Abstract] [Full Text] [Related]
12. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons. Yonekura S, Gotoh M, Kaneko S, Kanazawa K, Takeuji Y, Okubo K, Okamoto Y. Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168 [Abstract] [Full Text] [Related]
13. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract]. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T. Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178 [Abstract] [Full Text] [Related]
14. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS]. Yuta A, Ogawa Y, Kozaki H, Shimizu T. Arerugi; 2023 May; 72(10):1230-1239. PubMed ID: 38092399 [Abstract] [Full Text] [Related]
15. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood. Nomura T, Suzuki M, Yokota M, Nakamura Y, Ozeki K, Ito Y, Tsuge I, Saitoh S. Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747 [Abstract] [Full Text] [Related]
17. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal. Sakurai T, Yonekura S, Iinuma T, Sakurai D, Morimoto Y, Kaneko S, Okamoto Y. Int Arch Allergy Immunol; 2018 Jul; 177(3):245-254. PubMed ID: 30021201 [Abstract] [Full Text] [Related]
18. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H. Int Arch Allergy Immunol; 2008 Jul; 146(1):76-84. PubMed ID: 18087165 [Abstract] [Full Text] [Related]
19. Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets. Yonekura S, Gotoh M, Kaneko S, Maekawa Y, Okubo K, Okamoto Y. J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4103-4116.e14. PubMed ID: 34333190 [Abstract] [Full Text] [Related]
20. [Enhanced Clinical Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis in the Second Year of Treatment]. Yuta A, Ogawa Y, Suzuki Y, Arikata M, Kozaki H, Shimizu T, Ohta N. Nihon Jibiinkoka Gakkai Kaiho; 2017 Jan; 120(1):44-51. PubMed ID: 30035467 [Abstract] [Full Text] [Related] Page: [Next] [New Search]